GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Orgenesis Inc (FRA:45O) » Definitions » Cyclically Adjusted PB Ratio

Orgenesis (FRA:45O) Cyclically Adjusted PB Ratio : 0.38 (As of Sep. 22, 2024)


View and export this data going back to 2020. Start your Free Trial

What is Orgenesis Cyclically Adjusted PB Ratio?

As of today (2024-09-22), Orgenesis's current share price is €0.484. Orgenesis's Cyclically Adjusted Book per Share for the quarter that ended in Jun. 2024 was €1.26. Orgenesis's Cyclically Adjusted PB Ratio for today is 0.38.

The historical rank and industry rank for Orgenesis's Cyclically Adjusted PB Ratio or its related term are showing as below:

FRA:45O' s Cyclically Adjusted PB Ratio Range Over the Past 10 Years
Min: 0.22   Med: 5.63   Max: 31.26
Current: 0.39

During the past years, Orgenesis's highest Cyclically Adjusted PB Ratio was 31.26. The lowest was 0.22. And the median was 5.63.

FRA:45O's Cyclically Adjusted PB Ratio is ranked better than
74.26% of 606 companies
in the Biotechnology industry
Industry Median: 1.605 vs FRA:45O: 0.39

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted book value per share of a company over the past 10 years.

Orgenesis's adjusted book value per share data for the three months ended in Jun. 2024 was €-0.307. Add all the adjusted book value per share for the past 10 years together and divide the count will get our Cyclically Adjusted Book per Share, which is €1.26 for the trailing ten years ended in Jun. 2024.

Shiller PE for Stocks: The True Measure of Stock Valuation


Orgenesis Cyclically Adjusted PB Ratio Historical Data

The historical data trend for Orgenesis's Cyclically Adjusted PB Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Orgenesis Cyclically Adjusted PB Ratio Chart

Orgenesis Annual Data
Trend Nov14 Nov15 Nov16 Nov17 Nov18 Dec19 Dec20 Dec21 Dec22 Dec23
Cyclically Adjusted PB Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only 13.34 6.16 2.94 1.67 0.39

Orgenesis Quarterly Data
Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24
Cyclically Adjusted PB Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 1.11 0.48 0.39 0.63 0.46

Competitive Comparison of Orgenesis's Cyclically Adjusted PB Ratio

For the Biotechnology subindustry, Orgenesis's Cyclically Adjusted PB Ratio, along with its competitors' market caps and Cyclically Adjusted PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Orgenesis's Cyclically Adjusted PB Ratio Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Orgenesis's Cyclically Adjusted PB Ratio distribution charts can be found below:

* The bar in red indicates where Orgenesis's Cyclically Adjusted PB Ratio falls into.



Orgenesis Cyclically Adjusted PB Ratio Calculation

Like the Shiller PE Ratio, the Cyclically Adjusted PB Ratio takes the Book Value per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/B calculation. Because it considers this 10-year average, it's often referred to as the CAPB Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio.

Orgenesis's Cyclically Adjusted PB Ratio for today is calculated as

Cyclically Adjusted PB Ratio=Share Price/ Cyclically Adjusted Book per Share
=0.484/1.26
=0.38

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Orgenesis's Cyclically Adjusted Book per Share for the quarter that ended in Jun. 2024 is calculated as:

For example, Orgenesis's adjusted Book Value per Share data for the three months ended in Jun. 2024 was:

Adj_Book=Book Value per Share/CPI of Jun. 2024 (Change)*Current CPI (Jun. 2024)
=-0.307/132.5538*132.5538
=-0.307

Current CPI (Jun. 2024) = 132.5538.

Orgenesis Quarterly Data

Book Value per Share CPI Adj_Book
201408 -0.669 100.352 -0.884
201411 -0.512 99.635 -0.681
201502 -0.684 99.032 -0.916
201505 -0.969 100.333 -1.280
201508 -1.150 100.548 -1.516
201511 -1.290 100.135 -1.708
201602 1.661 100.040 2.201
201605 1.487 101.355 1.945
201608 1.333 101.617 1.739
201611 1.218 101.829 1.586
201702 0.552 102.779 0.712
201705 0.903 103.256 1.159
201708 0.969 103.587 1.240
201711 1.219 104.072 1.553
201802 1.536 105.052 1.938
201805 1.641 106.148 2.049
201808 1.884 106.383 2.347
201811 1.669 106.338 2.080
201903 1.141 107.251 1.410
201906 0.885 108.070 1.086
201909 0.589 108.329 0.721
201912 0.305 108.420 0.373
202003 4.412 108.902 5.370
202006 3.546 108.767 4.321
202009 3.330 109.815 4.020
202012 1.784 109.897 2.152
202103 1.877 111.754 2.226
202106 1.737 114.631 2.009
202109 1.494 115.734 1.711
202112 1.403 117.630 1.581
202203 1.269 121.301 1.387
202206 1.210 125.017 1.283
202209 1.194 125.227 1.264
202212 1.018 125.222 1.078
202303 0.927 127.348 0.965
202306 0.777 128.729 0.800
202309 0.381 129.860 0.389
202312 -0.604 129.419 -0.619
202403 -0.743 131.776 -0.747
202406 -0.307 132.554 -0.307

Add all the adjusted book value per share together and divide the count will get our Cyclically Adjusted Book per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


Orgenesis  (FRA:45O) Cyclically Adjusted PB Ratio Explanation

Compared with the regular PB Ratio, which works poorly for cyclical businesses, the Cyclically Adjusted PB Ratio smoothed out the fluctuations of book value during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Cyclically Adjusted PB Ratio should give similar results to regular PB Ratio.


Orgenesis Cyclically Adjusted PB Ratio Related Terms

Thank you for viewing the detailed overview of Orgenesis's Cyclically Adjusted PB Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Orgenesis Business Description

Industry
Traded in Other Exchanges
Address
20271 Goldenrod Lane, Germantown, MD, USA, 20876
Orgenesis Inc is a biotech company working to unlock the potential of cell and gene therapies. It is focused on autologous therapies, with processes and systems that are developed for each therapy using a closed and automated processing system approach that is validated for compliant production near the patient for treatment of the patient at the point of care (POCare). The Company's business includes two reporting segments: Morgenesis and Therapies.

Orgenesis Headlines

No Headlines